{
"id":"mk19_a_nr_s10",
"subspecialtyId":"nr",
"title":"Neuro-oncology",
"jsonContent":{
"type":"section",
"id":"mk19_a_nr_s10",
"title":{
"__html":"Neuro-oncology"
},
"titleNode":{
"type":"section-title",
"hlId":"fe9ca5",
"children":[
"Neuro-oncology"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s10_1",
"title":{
"__html":"Approach to Intracranial Tumors"
},
"titleNode":{
"type":"section-title",
"hlId":"7bf6aa",
"children":[
"Approach to Intracranial Tumors"
]
},
"children":[
{
"type":"p",
"hlId":"e75b37",
"children":[
"Both benign and malignant intracranial tumors can have devastating neurologic consequences because of the space constraints within the skull and potential surgical inaccessibility. Presenting symptoms of intracranial tumors appear in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t51",
"wrapId":"1",
"children":[
"Table 51"
]
}
]
},
". Intracranial tumors usually present with a slow, progressive course of symptoms. Acute symptoms typically occur when tumors cause seizure or hemorrhage."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_a_nr_t51"
]
},
{
"type":"p",
"hlId":"89a816",
"children":[
"Headache is a common symptom, although the classic early morning headache is uncommon. Elevated intracranial pressure (ICP) can cause the headache to increase with coughing, sneezing, straining, or the Valsalva maneuver. Elevated ICP also is associated with nausea, vomiting, blurry vision, papilledema, and an inability to abduct the eyes (bilateral abducens nerve [cranial nerve VI] palsy). Elevated ICP also can lead to life-threatening herniation, syncope, or cerebellar “fits” (episodic extension, flexion and stiffening of limbs; loss of consciousness; slowed or irregular respiration; and pupil dilation), which may be confused with seizures."
]
},
{
"type":"p",
"hlId":"9046b6",
"children":[
"Head CT without contrast may be useful emergently to assess for hemorrhage or herniation but is not sensitive for detecting the presence of a mass lesion, especially in the posterior fossa. Brain MRI is preferred; contrast administration improves diagnostic sensitivity. Management is determined by tumor location and pathology."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"6ad691",
"children":[
"Head CT without contrast may be useful emergently to assess for hemorrhage or herniation, but brain MRI is preferred for the evaluation of intracranial tumors."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_2",
"title":{
"__html":"Metastatic Brain Tumors"
},
"titleNode":{
"type":"section-title",
"hlId":"09e713",
"children":[
"Metastatic Brain Tumors"
]
},
"children":[
{
"type":"p",
"hlId":"26bf25",
"children":[
"Brain metastases are the most common intracranial tumors. The most likely sources are lung, breast, and kidney cancers and melanoma. Metastases can be solitary but are more often multiple. These metastases typically appear as ring-enhancing lesions on postcontrast MRIs, usually at the gray-white cortical junction. Survival is generally measured in weeks to months. Patients with symptomatic brain metastases should be considered for local therapy, including surgery or radiation therapy; most brain metastases are treated with whole-brain or more targeted radiation (stereotactic radiosurgery). Resection may increase survival in younger patients with good baseline function and a single or limited number of metastases and may benefit patients with large tumors and mass effect; it may also be considered when the underlying diagnosis is uncertain. Patients with multiple brain metastases and/or uncontrolled systemic disease are less likely to benefit from surgery unless the remaining disease is controllable with other measures."
]
},
{
"type":"p",
"hlId":"dccd5d",
"children":[
"Carcinomatous meningitis is a rare diagnosis that requires a high index of suspicion; presenting symptoms are variable and include head or neck pain, neurologic deficits, and altered mental status. MRI typically shows dural thickening with nodular enhancement. Patients with leukemia or lymphoma whose initial symptoms are cranial nerve deficits or radiculopathy may have evidence of nerve root enhancement on postcontrast MRI of the brain and/or spine. Cerebrospinal fluid (CSF) analysis with cytology and often flow cytometry is required to make the diagnosis; because of limited sensitivity, serial lumbar punctures are sometimes needed to establish the diagnosis."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"757a47",
"children":[
"Brain metastases are the most common intracranial tumors that typically appear as ring-enhancing lesions on postcontrast MRIs at the gray-white cortical junction."
]
},
{
"type":"keypoint",
"hlId":"b4194c",
"children":[
"Most brain metastases are treated with whole-brain or more targeted radiation (stereotactic radiosurgery), but resection of a single or limited number of intracranial metastases may increase survival in younger patients with good baseline function."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_3",
"title":{
"__html":"Primary Central Nervous System Tumors"
},
"titleNode":{
"type":"section-title",
"hlId":"73ce3b",
"children":[
"Primary Central Nervous System Tumors"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s10_3_1",
"title":{
"__html":"Meningiomas"
},
"titleNode":{
"type":"section-title",
"hlId":"a41203",
"children":[
"Meningiomas"
]
},
"children":[
{
"type":"p",
"hlId":"77471d",
"children":[
"Meningioma is the most common primary central nervous system (CNS) tumor. Often found incidentally, meningiomas are benign dural-based tumors that typically show homogenous enhancement on postcontrast MRI. They have a smooth, rounded shape and often a “tail” that tracks along the dura outside the brain parenchyma ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f32",
"wrapId":"2",
"children":[
"Figure 32"
]
}
]
},
")"
]
},
". On noncontrast images, meningiomas may be hypointense or isointense and thus not readily seen. Because of their characteristic MRI appearance, many meningiomas are followed clinically, without resection or biopsy, unless they are accompanied by significant clinical deficits, drug-resistant seizures, severe headaches, or peritumoral edema."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_a_nr_f32"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"7b2546",
"children":[
"Meningioma is the most common primary type of central nervous system tumor; they typically have a smooth, rounded shape and often a “tail” that tracks along the dura outside the brain parenchyma and homogenous enhancement on postcontrast MRI."
]
},
{
"type":"keypoint",
"hlId":"899034",
"children":[
"Meningiomas are resected only if accompanied by significant clinical deficits, drug-resistant seizures, severe headaches, or peritumoral edema."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_3_2",
"title":{
"__html":"Glioblastoma Multiforme"
},
"titleNode":{
"type":"section-title",
"hlId":"824b60",
"children":[
"Glioblastoma Multiforme"
]
},
"children":[
{
"type":"p",
"hlId":"822aa0",
"children":[
"Glioblastoma multiforme ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"figure-link",
"target":"mk19_a_nr_f33",
"wrapId":"3",
"children":[
"Figure 33"
]
}
]
},
")"
]
},
" is the most common and most aggressive glioma subtype in adults. Previous exposure to medical therapeutic radiation is the only consistent risk factor for developing gliomas. There is no evidence that environmental electromagnetic fields, cell phones, or smoking increase tumor risk. Gliomas rarely metastasize, and routine evaluation of patients with glioblastoma multiforme with lumbar puncture or MRI of the spinal cord is not recommended unless dictated by focal findings."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_a_nr_f33"
]
},
{
"type":"p",
"hlId":"5c1db5",
"children":[
"An MRI typically shows a large, space-occupying lesion with central necrosis, mass effect, and surrounding edema. Lower-grade gliomas may not enhance. Treatment is usually resection, if possible, followed by radiation and chemotherapy. Temozolomide, nitrosoureas, and bevacizumab can be used. Prognosis is dependent on pathologic type; 5-year survival rates for glioblastoma multiforme are less than 10%, and survival is often measured in months. Prognosis is better in patients who are younger than 45 years, have an excellent functional status, have minimal residual tumor after resection, and receive chemotherapy and radiation after surgery."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"50ee4c",
"children":[
"Previous exposure to medical therapeutic radiation is the only consistent risk factor for developing gliomas, including glioblastoma multiforme."
]
},
{
"type":"keypoint",
"hlId":"90212f",
"children":[
"Prognosis in glioblastoma multiforme is better in patients who are younger than 45 years, have an excellent functional status, have minimal residual tumor after resection, and receive chemotherapy and radiation after surgery."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_3_3",
"title":{
"__html":"Primary Central Nervous System Lymphoma"
},
"titleNode":{
"type":"section-title",
"hlId":"467189",
"children":[
"Primary Central Nervous System Lymphoma"
]
},
"children":[
{
"type":"p",
"hlId":"21d7f6",
"children":[
"Primary CNS lymphoma (PCNSL) initially occurs without systemic or lymph node involvement. Its typical pathologic appearance is diffuse large B-cell lymphoma. On MRI, PCNSL appears as a single, well-demarcated, deep white matter (periventricular) lesion with minimal mass effect or edema."
]
},
{
"type":"p",
"hlId":"82aba6",
"children":[
"PCNSL evaluation should include HIV testing, lumbar puncture (if not contraindicated because of elevated ICP), and ophthalmologic evaluation with vitreous fluid sampling. Lymphomatous cells in vitreous or CSF samples can add to diagnostic sensitivity and may obviate the need for biopsy. Systemic staging should include bone marrow biopsy, testicular ultrasonography, and whole-body PET or CT. Empiric glucocorticoids should be avoided before biopsy because they can temporarily suppress lymphoma and prevent or delay a tissue diagnosis."
]
},
{
"type":"p",
"hlId":"00a98b",
"children":[
"High-dose intravenous (IV) methotrexate combined with rituximab is the mainstay of treatment and at times is followed by subsequent radiation. Despite being chemo- and radiosensitive, PCNSL typically has multiple recurrences and a generally poor prognosis."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"45eee3",
"children":[
"Lymphomatous cells in vitreous or cerebral spinal fluid samples may obviate the need for biopsy in diagnosing primary central nervous system lymphoma."
]
},
{
"type":"keypoint",
"hlId":"8a17fd",
"children":[
"Empiric glucocorticoids should be avoided before biopsy because they can temporarily suppress lymphoma and prevent or delay a tissue diagnosis."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_4",
"title":{
"__html":"Medical Management of Complications of Central Nervous System Tumors"
},
"titleNode":{
"type":"section-title",
"hlId":"ee45c6",
"children":[
"Medical Management of Complications of Central Nervous System Tumors"
]
},
"children":[
{
"type":"section",
"id":"mk19_a_nr_s10_4_1",
"title":{
"__html":"Seizures"
},
"titleNode":{
"type":"section-title",
"hlId":"ac24a7",
"children":[
"Seizures"
]
},
"children":[
{
"type":"p",
"hlId":"70ce3c",
"children":[
"Seizures are more common in low-grade than high-grade tumors. Tumors near the cortex, especially the temporal lobe or primary motor cortex, are especially associated with seizures. White matter and posterior fossa tumors, on the other hand, typically do not cause seizures. Gangliogliomas and dysembryoplastic neuroepithelial tumors cause medication-resistant seizures in more than 90% of patients, and these tumors should be resected, if possible. Seizures may not be directly caused by the CNS tumor but rather by associated conditions or treatment, such as electrolyte disturbances, infection, chemotherapy, or paraneoplastic encephalitis."
]
},
{
"type":"p",
"hlId":"75288a",
"children":[
"In patients with CNS tumors not associated with seizures, prophylactic antiepileptic drugs (AEDs) are not recommended. In patients undergoing surgery for CNS tumors, evidence is insufficient to support the use of AEDs to reduce the risk of peri- or postoperative seizures. In patients with seizures, older AEDs (phenobarbital, phenytoin, valproic acid, carbamazepine) should be avoided because of drug interactions and adverse effects. Levetiracetam and lacosamide are preferred because of their lack of drug interactions, IV availability, better tolerability, and rapid titration to a therapeutic dose. Unprovoked seizures occurring after resection typically require lifelong AED treatment."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"c34bca",
"children":[
"Gangliogliomas and dysembryoplastic neuroepithelial tumors provoke medication-resistant seizures in more than 90% of patients; therefore, patients with these tumors should be referred for resection, if possible."
]
},
{
"type":"keypoint",
"hlId":"fbe2fa",
"hvc":true,
"children":[
"In patients with central nervous system tumors not associated with seizures, prophylactic antiepileptic drugs are not recommended."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_4_2",
"title":{
"__html":"Edema and Herniation"
},
"titleNode":{
"type":"section-title",
"hlId":"2dcdd0",
"children":[
"Edema and Herniation"
]
},
"children":[
{
"type":"p",
"hlId":"396b3f",
"children":[
"Brain edema can lead to focal neurologic deficits, elevated ICP, or herniation. Brain herniation manifests as an abrupt decline in mental status, unreactive dilated pupils, and motor weakness with flexor or extensor posturing. Emergent treatment to prevent death includes elevation of the head of the bed to 30 degrees, hyperventilation (usually with mechanical ventilation), infusion of either hypertonic saline or mannitol, and administration of glucocorticoids. These treatments can be life-saving and often are used as a bridge to emergent surgery. Among glucocorticoids, dexamethasone is preferred because of its lack of mineralocorticoid effects. Antiangiogenic agents, such as bevacizumab, can be used as glucocorticoid-sparing agents but take weeks or months to have an effect."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"6cef49",
"children":[
"Emergent treatment, including elevation of the head of the bed, hyperventilation, infusion of either hypertonic saline or mannitol, and administration of glucocorticoids, is necessary to prevent death in patients with brain herniation."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_4_3",
"title":{
"__html":"Venous Thromboembolism"
},
"titleNode":{
"type":"section-title",
"hlId":"934476",
"children":[
"Venous Thromboembolism"
]
},
"children":[
{
"type":"p",
"hlId":"8bb82c",
"children":[
"Certain characteristics are associated with increased venous thromboembolism risk in patients with CNS tumors ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t52",
"wrapId":"4",
"children":[
"Table 52"
]
}
]
},
")"
]
},
". Despite the risk of intracranial hemorrhage, therapeutic anticoagulation is generally recommended in confirmed thromboembolic disease. Anticoagulation has historically been avoided in melanoma, choriocarcinoma, papillary thyroid carcinoma, and renal carcinoma because of an assumed increased risk of hemorrhage. However, recent studies have not shown that anticoagulation increases hemorrhage risk in patients with these cancers. Besides the usual contraindications, anticoagulation should be avoided in patients with previous intracranial hemorrhage and a platelet count less than 50,000/μL (50 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L). The presence of a CNS tumor is a contraindication for thrombolytic therapy in pulmonary embolism, although exceptions may be made for low-risk tumors, such as meningiomas. Expert opinion recommends preanticoagulation neuroimaging with CT to assess for hemorrhage."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_a_nr_t52"
]
},
{
"type":"p",
"hlId":"3334d3",
"children":[
"Low-molecular-weight heparin is generally preferred over unfractionated heparin. Exceptions include kidney impairment and a higher hemorrhage risk when rapid reversal may be required. Inferior vena cava filters have considerably high rates of complications and should be reserved for patients with an absolute contraindication to anticoagulation. Warfarin or low-molecular-weight heparin may be considered for long-term therapy, although medication interactions between warfarin and chemotherapy or AEDs are a concern. Evidence is insufficient to recommend direct oral anticoagulants for patients with CNS tumors."
]
},
{
"type":"p",
"hlId":"e86ff4",
"children":[
"Prophylactic anticoagulation in combination with mechanical devices is recommended in hospitalized patients with CNS tumors as soon as possible after resection. Chronic outpatient prophylactic anticoagulation is not recommended."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"ad18e7",
"children":[
"Despite the risk of intracranial hemorrhage, therapeutic anticoagulation is generally recommended in confirmed venous thromboembolic disease."
]
},
{
"type":"keypoint",
"hlId":"1ddeb6",
"children":[
"Prophylactic anticoagulation in combination with mechanical devices is recommended in hospitalized patients with central nervous system tumors as soon as possible after resection."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_5",
"title":{
"__html":"Paraneoplastic/Autoimmune Neurologic Syndromes"
},
"titleNode":{
"type":"section-title",
"hlId":"20b1a0",
"children":[
"Paraneoplastic/Autoimmune Neurologic Syndromes"
]
},
"children":[
{
"type":"p",
"hlId":"c769d1",
"children":[
"Antibody-mediated neurologic syndromes may occur as primary autoimmune or paraneoplastic disorders. Various syndromes have been described with different neurologic manifestations and findings on serum and CSF studies ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_a_nr_t53",
"wrapId":"5",
"children":[
"Table 53"
]
}
]
},
")"
]
},
". Limbic encephalitis is one of the most common presentations and manifests as acute or subacute mood and behavioral changes, short-term memory problems, seizures, and cognitive dysfunction; thus, it may appear as a rapidly progressive dementia. Other “red flag” symptoms include new-onset status epilepticus or psychosis in a previously healthy patient, acute movement disorder (ataxia, chorea, myoclonus, tremor), acute progressive peripheral neuropathy, systemic evidence of autoimmune disease (thyroid disease, type 1 diabetes mellitus), and systemic signs of malignancy (severe anorexia, weight loss, lymphadenopathy)."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_a_nr_t53"
]
},
{
"type":"p",
"hlId":"80c90c",
"children":[
"In suspect cases, the patient should be thoroughly evaluated for an antibody-mediated process and for systemic cancer, which may include surveillance for years after the primary syndrome is diagnosed. Evaluation should include brain MRI with contrast, antibody testing of the blood and CSF, and imaging (full-body CT, body and brain PET, and ultrasonography, as appropriate) for tumor detection."
]
},
{
"type":"p",
"hlId":"229b34",
"children":[
"Treating the symptoms directly (with, for example, AEDs or antipsychotic agents) is typically ineffective without appropriate tumor resection and immunotherapy. Even when the tumor is removed, long-term immunotherapy may be needed. Acute management with IV immune globulin or IV methylprednisolone is often helpful. Chronic treatment with azathioprine, mycophenolate, cyclophosphamide, or rituximab may be considered."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"a69dc5",
"children":[
"Paraneoplastic/autoimmune limbic encephalitis presents as acute or subacute mood and behavioral changes, short-term memory problems, seizures, and cognitive dysfunction and thus may appear as a rapidly progressive dementia"
]
},
{
"type":"keypoint",
"hlId":"c7d483",
"children":[
"In suspect cases, the patient should be thoroughly evaluated for an antibody-mediated process and for systemic cancer, which sometimes includes surveillance that continues for years after the primary syndrome is diagnosed."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_a_nr_s10_6",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Englot DJ, Magill ST, Han SJ, et al. Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg. 2016;124:1552-61. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26636386",
"target":"_blank"
},
"children":[
"PMID: 26636386"
]
},
" doi:10.3171/2015.4.JNS142742"
]
},
{
"type":"reference",
"children":[
"Han CH, Batchelor TT. Primary central nervous system lymphoma. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1601-18."
]
},
{
"type":"reference",
"children":[
"Hoang-Xuan K, Bessell E, Bromberg J, et al; European Association for Neuro-Oncology Task Force on Primary CNS Lymphoma. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015 Jul;16(7):e322-32. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/26149884",
"target":"_blank"
},
"children":[
"PMID: 26149884"
]
},
" doi:10.1016/S1470-2045(15)00076-5."
]
},
{
"type":"reference",
"children":[
"Lancaster E. Paraneoplastic disorders. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1653-79."
]
},
{
"type":"reference",
"children":[
"McKeon A. Autoimmune encephalopathies and dementias. Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):538-58. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27042907",
"target":"_blank"
},
"children":[
"PMID: 27042907"
]
},
" doi:10.1212/CON.0000000000000299."
]
},
{
"type":"reference",
"children":[
"Mohile NA. Medical complications of brain tumors. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1635-52."
]
},
{
"type":"reference",
"children":[
"Strowd III RE, Blakeley JO. Common histologically benign tumors of the brain. CONTINUUM: Lifelong Learning in Neurology. 2017 Dec 1;23(6):1680-708."
]
},
{
"type":"reference",
"children":[
"Vogelbaum MA, Brown PD, Messersmith H, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40:492-516. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34932393",
"target":"_blank"
},
"children":[
"PMID: 34932393"
]
},
" doi:10.1200/JCO.21.02314"
]
},
{
"type":"reference",
"children":[
"Walbert T, Harrison RA, Schiff D, et al. SNO and EANO practice guideline update: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro Oncol. 2021;23:1835-1844. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/34174071",
"target":"_blank"
},
"children":[
"PMID: 34174071"
]
},
" doi:10.1093/neuonc/noab152"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_a_nr_t51":{
"id":"mk19_a_nr_t51",
"number":51,
"bookId":"nr",
"title":{
"__html":"Presenting Symptoms/Findings of Central Nervous System Tumors"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"def8cf",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 51. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t51"
}
]
},
"Presenting Symptoms/Findings of Central Nervous System Tumors"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"34fed3",
"class":"col hd l",
"children":[
"Tumor Location"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"61a419",
"class":"col hd l",
"children":[
"Symptoms/Findings"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b6adc",
"class":"cell txt l",
"children":[
"Brainstem"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d1db0f",
"class":"cell txt l",
"children":[
"Cranial nerve findings, elevated intracranial pressure",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c2128",
"class":"cell txt l",
"children":[
"Cerebellum"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8d5c36",
"class":"cell txt l",
"children":[
"Ataxia, falls, imbalance, elevated intracranial pressure",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"192024",
"class":"cell txt l",
"children":[
"Frontal lobe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bd7c40",
"class":"cell txt l",
"children":[
"Weakness, personality change, cognitive symptoms, or psychiatric symptoms"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fcc6f7",
"class":"cell txt l",
"children":[
"Occipital lobe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"63a755",
"class":"cell txt l",
"children":[
"Homonymous hemianopia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8abbc2",
"class":"cell txt l",
"children":[
"Parietal lobe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e3d94",
"class":"cell txt l",
"children":[
"Numbness, paresthesia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"779d25",
"class":"cell txt l",
"children":[
"Temporal lobe"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d50be1",
"class":"cell txt l",
"children":[
"Amnesia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"18da64",
"class":"cell txt l",
"children":[
"Dominant hemisphere"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5d2051",
"class":"cell txt l",
"children":[
"Aphasia"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Symptoms of elevated intracranial pressure include nausea, vomiting, blurry vision, papilledema, and inability to abduct the eyes (bilateral abducens nerve [cranial nerve VI] palsy)."
]
]
},
"mk19_a_nr_t52":{
"id":"mk19_a_nr_t52",
"number":52,
"bookId":"nr",
"title":{
"__html":"Risk Factors for Venous Thromboembolism in Patients with Central Nervous System Tumors"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"237174",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 52. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t52"
}
]
},
"Risk Factors for Venous Thromboembolism in Patients with Central Nervous System Tumors"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c16804",
"class":"cell txt l",
"children":[
"Age >75 years"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d16d2b",
"class":"cell txt l",
"children":[
"Prolonged immobility or leg weakness"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0436ee",
"class":"cell txt l",
"children":[
"Indwelling vascular catheter"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"18eb20",
"class":"cell txt l",
"children":[
"Prior venous thromboembolism"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"156e7c",
"class":"cell txt l",
"children":[
"Glioblastoma multiforme"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"24dc5f",
"class":"cell txt l",
"children":[
"Glioma >5 cm"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1ad9cb",
"class":"cell txt l",
"children":[
"Chemotherapy, particularly hormonal or antiangiogenic agents"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"381d65",
"class":"cell txt l",
"children":[
"Recurrent tumor"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f9ef07",
"class":"cell txt l",
"children":[
"Incomplete resection"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bb5880",
"class":"cell txt l",
"children":[
"Immediate postresection period"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_a_nr_t53":{
"id":"mk19_a_nr_t53",
"number":53,
"bookId":"nr",
"title":{
"__html":"Common Autoimmune and Paraneoplastic Neurologic Disorders"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"545993",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 53. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_nr_t53"
}
]
},
"Common Autoimmune and Paraneoplastic Neurologic Disorders"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6f071b",
"class":"col hd l",
"children":[
"Clinical Presentation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a1e9de",
"class":"col hd l",
"children":[
"Associated Cancers"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1c0ea3",
"class":"col hd l",
"children":[
"Autoantibody Targets"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ef63d8",
"class":"cell txt l",
"children":[
"Limbic encephalitis,",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" psychosis, chorea, dysautonomia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"55a1e0",
"class":"cell txt l",
"children":[
"Ovarian teratoma"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"22a2b2",
"class":"cell txt l",
"children":[
"NMDA receptor",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0113f6",
"class":"cell txt l",
"children":[
"Limbic encephalitis,",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" executive dysfunction, personality change, brainstem/limbic encephalitis",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
", myoclonus, neuropathy, hyponatremia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"393649",
"class":"cell txt l",
"children":[
"SCLC"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c8f538",
"class":"cell txt l",
"children":[
"VGKC receptor complex",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
" (includes LGI1, CASPR2, contactin-2)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cdb725",
"class":"cell txt l",
"children":[
"Limbic encephalitis,",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" brainstem encephalitis, autonomic or sensory neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"393649",
"class":"cell txt l",
"children":[
"SCLC"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5c1960",
"class":"cell txt l",
"children":[
"ANNA-1 (Hu)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0337e6",
"class":"cell txt l",
"children":[
"Ataxia, brainstem encephalitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c3e264",
"class":"cell txt l",
"children":[
"Breast cancer, SCLC, gynecologic cancer"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4cabca",
"class":"cell txt l",
"children":[
"ANNA-2 (Ri)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7ee264",
"class":"cell txt l",
"children":[
"Ataxia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"936713",
"class":"cell txt l",
"children":[
"Gynecologic cancer, breast cancer"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a67a1b",
"class":"cell txt l",
"children":[
"PCA-1 (Yo)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b9557e",
"class":"cell txt l",
"children":[
"Limbic encephalitis,",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" brainstem encephalitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"390093",
"class":"cell txt l",
"children":[
"Testicular cancer"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"055015",
"class":"cell txt l",
"children":[
"Ma1, Ma2"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1ca14c",
"class":"cell txt l",
"children":[
"Dementia, personality change, chorea, ataxia, neuropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5c7542",
"class":"cell txt l",
"children":[
"SCLC, thymoma"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"19241a",
"class":"cell txt l",
"children":[
"CRMP5"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01dcdf",
"class":"cell txt l",
"children":[
"Stiff-person syndrome, type 1 diabetes mellitus, ataxia, brainstem encephalitis, ophthalmoplegia, parkinsonism"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e06e20",
"class":"cell txt l",
"children":[
"Thymoma, breast cancer"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2d86db",
"class":"cell txt l",
"children":[
"GAD",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ANNA = antineuronal nuclear antigen; CASPR = contactin associated protein-like; CRMP = collapsin response mediator protein; GAD = glutamic acid decarboxylase; LGI = leucine-rich, glioma inactivated; NMDA = ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"N"
]
},
"-methyl-",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"D"
]
},
"-aspartate; PCA = Purkinje-cell antibody; SCLC = small cell lung cancer; VGKC = voltage-gated potassium channel."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Acute or subacute mood and behavioral changes, short-term memory problems, seizures, and cognitive dysfunction."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Not necessarily associated with paraneoplastic syndromes; may be primary autoimmune, without cancer."
]
]
}
}
}